Regular CSF-analysis by blood-gas-analyzers in order to detect bacterial or mycotic CSF-infection

Regular CSF-analysis by blood-gas-analyzers in order to detect bacterial or mycotic CSF-infection - Liquor-Lac-II

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00031389

Enrollment

100

Registered

2023-03-01

Start date

2023-04-21

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Z98.2

Interventions

Group 1: Population: - All patients on an intensive care unit with a continuous temporary CSF-drainage Diagnostic method: - CSF-analysis by a blood-gas-analyzer - once a day Group 2: Population: - Al

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Therapeutic need of a temporary CSF-drainage

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Accuracy and velocity of detecting CSF-infections by CSF-analysis via a blood-gas-analyzer as compared to neurochemical standard diagnostics	—

Secondary

Measure	Time frame
Evaluation of the CSF-lactate-to-CSF-glucose-ratio in diagnosing bacterial or mycotic CSF-infections	—

Countries

Germany

Contacts

Public ContactCaspar Stephani

Universitätsmedizin Göttingen

Caspar.Stephani@med.uni-goettingen.de+491753431572

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026